Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Arachidonic Acid	302.15M
Arachidonic Acid Growth	18.22%
Docosahexaenoic Acid	79.43M
Docosahexaenoic Acid Growth	23.09%
Sialic Acid	23.21M
Sialic Acid Growth	-32.60%
Other Business	8.41M
Other Business Growth	-73.16%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	271.23M
China Growth	17.17%
Overseas	164.16M
Overseas Growth	-3.77%